CENTRE FOR INNOVATION IN REGULATORY SCIENCE
Centre for Innovation in Regulatory Science is a neutral, independently managed UK-based subsidiary company, forming part of the Clarivate Analytics group. CIRS provides an international forum for industry, regulators, HTA and other healthcare stakeholders to meet, debate and develop regulatory and reimbursement policy through the innovative application of regulatory science and to facilitate access to medical products. This is CIRSโ purpose. CIRS is operated solely for promotion of its purpose. The organisation has its own dedicated management and advisory boards, and its funding is derived from membership dues, related activities, special projects and grants.
CENTRE FOR INNOVATION IN REGULATORY SCIENCE
Social Links:
Industry:
Biotechnology Innovation Management Non Profit
Founded:
2005-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cirsci.org
Total Employee:
1+
Status:
Active
Total Funding:
1.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag WordPress 5.3 ConvertPlug
Similar Organizations
FIRST
FIRST aims to inspire young people to be science and technology leaders.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nationโs leading comprehensive, integrated health systems.
Reaction Biology
Reaction Biology is an industry leader and innovator specializing in assay services and protein production for early-stage drug discovery
Science Center
The University City Science Center accelerates technology commercialization, regional economic development, and the market availability of
Current Employees Featured
Founder
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Centre for Innovation in Regulatory Science
Official Site Inspections
http://www.cirsci.org
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Centre for Innovation in Regulatory Science"
About us โ CIRS - cirsci.org
What makes us unique What sets us apart is our ability to facilitate safe harbour discussions between multiple stakeholders involved in drug development and patient access to medicines. CIRS meetings are usually small, focused and โฆSee details»
Regulatory strengthening (OpERA) โ CIRS - cirsci.org
Strengthening regulatory systems is key to ensuring that regulatory agencies are providing effective and efficient services to their stakeholders. Over the past 20 years, CIRS has played an active role in this area by collecting performance โฆSee details»
CIRS - Centre for Innovation in Regulatory Science - LinkedIn
The Centre for Innovation in Regulatory Science (CIRS) is a neutral, independently managed UK-based subsidiary of Clarivate plc. CIRS provides an international forum for industry, regulators, โฆSee details»
2019 PROJECT REPORT - ICH
Centre for Innovation in Regulatory Science (CIRS) Magda Bujar, Manager, Strategic Development Neil McAuslane, Scientific Director - www.cirsci.org CIRS - The Centre for โฆSee details»
CIRS - Centre for Innovation in Regulatory Scienceโs Post - LinkedIn
CIRS RD Briefing 87 โ A Roadmap for Regulatory Strengthening: CIRS Tools for Measuring and Optimising Regulatory Performance to Support Practices in Line with the World Health โฆSee details»
Centre for Innovation in Regulatory Science - Devex
Learn more about Centre for Innovation in Regulatory Science's jobs, projects, latest news, contact information and geographical presence. The Centre for Innovation in Regulatory โฆSee details»
Centre for Innovation in Regulatory Science Awarded a $1.09m โฆ
Mar 9, 2020 The grant has been awarded to CIRS for the purpose of 'Tracking Regulatory Performance Metrics in Low and Middle Income Countries' to accelerate and consolidate the โฆSee details»
Publications โ CIRS - cirsci.org
Mar 8, 2015 Introduction: The World Health Organization (WHO) advocates the use of reliance practices to enable national regulatory authorities (NRAs) to improve patientsโ access to medicines.See details»
Medical device and diagnostic pricing and reimbursement in Canada
HTX.ca, a provincial organization dedicated to helping Ontario-based medical device companies to develop, produce, and commercialize innovative market-leading advanced health โฆSee details»
The Benefit-Risk Assessment of Medicines: Experience of a โฆ
Dec 30, 2017 Background In 2008, a consortium of 4 regulatory authorities, the Australian Therapeutic Goods Administration (TGA), Health Canada, Swissmedic, and Singapore Health โฆSee details»
Lawrence E. Liberti - Pharmaceutical Policy
Class of: 2013 Current affiliation: CIRS Contact: [email protected] Education and experience: Mr Liberti is the Executive Director of CIRS (the Centre for Innovation in Regulatory Science, Ltd. โฆSee details»
A Proposed Framework for a Globally Applicable Pragmatic โฆ
Affiliations 1 Centre for Innovation in Regulatory Science (CIRS), 160 Blackfriars Road, London, SE1 8EZ, United Kingdom. [email protected]. 2 Utrecht Institute for Pharmaceutical Sciences, โฆSee details»
CIRS Membership - cirsci.org
Membership to the CIRS Regulatory and Access programme is open to all pharmaceutical companies, particularly those engaged in research and development of new active โฆSee details»
Building Synergy between Regulatory and HTA Agencies beyond โฆ
The study showed that the gap between regulatory and HTA requirements has narrowed over the past 5 years. All respondents supported synergy between regulatory and HTA stakeholders, โฆSee details»
Accelerating access to new medicines: Current status of facilitated ...
Aug 6, 2015 University 3584 CS Utrecht, The Netherlands eThe Bill and Melinda Gates Foundation, Seattle, WA 98109, USA ^Temple University School of Pharmacy, Philadelphia, โฆSee details»
Evaluation of the Performance of the South Africa Regulatory โฆ
Abstract Background: Timely access to new medicines may be addressed through strengthening of registration efficiencies and timelines by establishing and refining value-added registration โฆSee details»
2023 Annual Report - cirsci.org
2024-2026 period. This strategic planning was a comprehensive process, beginning with the Topic Groups initiative, which engaged representatives from member companies, regulatory โฆSee details»
ORGANIZATIONS - Roberts Space Industries
Welcome Citizen to the RSI Organizations system. Organizations gather members of the RSI community around their shared interest and vision for the game. Browse the Organization Hub โฆSee details»
2022 Annual Report - cirsci.org
This Annual Report provides a brief snapshot of our work in the Regulatory and HTA policy space. It includes details of our Multi-stakeholder Workshops, Technical Fora, Industry Discussion โฆSee details»